ArgáMedtech is an innovative brand that specializes in the development of advanced cardiac ablation systems for the treatment of cardiac arrhythmias. The brand is backed by venture capital and is dedicated to helping patients with Atrial Fibrillation, a global epidemic affecting millions of people worldwide. Atrial Fibrillation patients face a higher risk of stroke and heart failure, leading to a significantly reduced quality of life.

While cardiac ablation is the preferred intervention therapy, the current technology has only shown marginal improvements in outcomes over the past 15 years. To address this challenge, ArgáMedtech is working on a next-generation non-thermal cardiac ablation system. Their unique Pulsed Field Ablation power generator, combined with their proprietary catheter, offers unparalleled flexibility in delivering therapy.

The system called Coherent Sine-burst Electroporation (CSE) allows for precise lesion depth control and transmurality, eliminating the need for catheter exchanges during procedures. ArgáMedtech understands that success in cardiac ablation requires both a superior catheter design and an advanced energy delivery generator. With their cutting-edge technology, ArgáMedtech aims to create safer, faster, and more efficient solutions, ultimately improving long-term outcomes for patients